Evidence map›Paper›PMID 23071105›Full record

ArticleMolecular pharmacology2013

Pivotal role of reactive oxygen species in differential regulation of lipopolysaccharide-induced prostaglandins production in macrophages.

Guiqing Zhao, Rui Yu, Jing Deng, Qiong Zhao, Yongchao Li, Myungsoo Joo, Richard B van Breemen, John W Christman, Lei Xiao

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Monocytes and Macrophages Serve as Potent Prostaglandin DInternational journal of molecular sciences · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Guiqing ZhaoDepartment of Medicine, M/C: 719 University of Illinois at Chicago 840 S. Wood Street Chicago, IL 60612, USA.
Rui Yu
Jing Deng
Qiong Zhao
Yongchao Li
Myungsoo Joo
Richard B van Breemen
John W Christman
Lei Xiao
Pusan National University · KRUniversity of Illinois Chicago · USJesse Brown VA Medical Center · USNorthwestern University · US

Funding

Van Breemen: Project 3; Botanical Dietary Supplements - Metabolism and Safety in Women (Van Breemen)P50AT000155 · NCCIH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PAULI, GUIDO F · 1999 to 2019
$30.4M
Macrophage Gene Expression in Acute Lung InflammationR01HL075557 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CHRISTMAN, JOHN W · 2004 to 2016
$4.8M
Role of p67phox in myocardial hypertrophyR01HL083218 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI XIAO, LEI · 2008 to 2013
$2.0M
NADPH OXIDASE REGULATION OF THE MACROPHAGE INFLAMMATORY PHENOTYPE IN SEPSISR01HL103643 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI CHRISTMAN, JOHN W · 2010 to 2013
$1.5M
Regulation of Neutrophilic Lung InflammationI01BX000108 · VA · JESSE BROWN VA MEDICAL CENTER · PI CHRISTMAN, JOHN W · 2009 to 2013
–
BLRD VA I01 BX000108NCCIH NIH HHS P50 AT000155NCCIH NIH HHS P50-AT000155NHLBI NIH HHS 1R01-HL083218NHLBI NIH HHS 3R01-HL083218-01A2S1NHLBI NIH HHS 5R01-HL075557NHLBI NIH HHS R01 HL075557NHLBI NIH HHS R01 HL083218NHLBI NIH HHS R01 HL103643
6 · The paper itself

Abstract

Gram-negative bacterial endotoxin lipopolysaccharide (LPS) triggers the production of inflammatory cytokines, reactive oxygen species (ROS), and prostaglandins (PGs) by pulmonary macrophages. Here, we investigated if ROS influenced PGs production in response to LPS treatment in mouse bone marrow-derived macrophages (BMDM). We observed that pretreatment of BMDM with two structurally unrelated ROS scavengers, MnTMPyP and EUK-134, not only prevented LPS-induced ROS accumulation, but also attenuated the LPS-induced PGD(2), but not PGE(2), production. Conversely LPS-induced PGD(2), but not PGE(2), production, was potentiated with the cotreatment of BMDM with H(2)O(2). These data suggest that ROS differentially regulate PGD(2) and PGE(2) production in BMDM. In addition, selective inhibition of the ROS generator NADPH oxidase (NOX) using either pharmacologic inhibitors or its p47(phox) subunit deficient mouse BMDM also attenuated LPS-induced PGD(2), but not PGE(2) production, suggesting the critical role of NOX-generated ROS in LPS-induced PGD(2) production in BMDM. We further found that both hematopoietic PGD synthase (H-PGDS) siRNA and its inhibitor HQL-79, but not lipocalin PGDS (L-PGDS) siRNA and its inhibitor AT-56, significantly attenuated LPS-induced PGD(2) production, suggesting that H-PGDS, but not L-PGDS, mediates LPS-induced PGD(2) production in BMDM. Furthermore, data from our in vitro cell-free enzymatic studies showed that coincubation of the recombinant H-PGDS with either MnTMPyP, EUK-134, or catalase significantly decreased PGD(2) production, whereas coincubation with H(2)O(2) significantly increased PGD(2) production. Taken together, our results show that LPS-induced NOX-generated ROS production differentially and specifically regulates the H-PGDS-mediated production of PGD(2), but not PGE(2), in mouse BMDM.

Indexed as

AnimalsIntramolecular OxidoreductasesLipocalinsLipopolysaccharidesMacrophagesMaleMiceMice, Inbred C57BLMice, KnockoutNADPH OxidasesProstaglandin D2Reactive Oxygen SpeciesSignal TransductionZymosanIntramolecular OxidoreductasesLipocalinsLipopolysaccharidesNADPH Oxidasesneutrophil cytosolic factor 1Prostaglandin D2prostaglandin R2 D-isomeraseReactive Oxygen SpeciesZymosan

Identifiers

PMID23071105
PMCPMC3533474
OpenAlexW2114245800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.